Indian Companies Invest In Foreign Companies For Pharmaceutical Research

By Author: Mrssindia
Total Articles: 2
Comment this article

Indian companies are going aggressive in terms of research and development. Particularly, pharmaceutical sector relies heavily on it. Pharma Research India goes to a higher plane with the announcement of Indian companies buying European drug companies for the sole purpose of conducting fundamental pharmaceutical research. Recently, Ajay Piramal group captured the headlines of business channels and newspapers. Since research has been the weak link in the Indian market, this step will make it strong and effective. The European company will not only help in performing the basic research but also contribute by collaborating with top-notch universities and other institutes to carry out meaningful work.

It is a costly affair

By all means, it is a costly affair to set research and development infrastructure for pharma sector. You need state-of-the-art facilities, equipment and tools. Millions of dollars of investment is required to form the setup. Since the situation of Digital Research India is still at primitive levels, such initiatives will improve the situation and take it to further heights. It is the reason Indian ...
... drug companies have started allocating a separate budget for research activities. The old-fashioned business model of copying patent drugs and churning out the maximum possible production till the patent license expires is no longer effective. Now, there is a need for spending adequately on research activity.

Since Indian economy has improved phenomenally in last two decades, companies have the potential of spending for research. There have been setbacks to it because of the reluctance of entrepreneurs earlier; the situation is different now. Companies like Piramal are spending millions of dollars on it. Brands that are in the business of drugs and healthcare want to find out new and effective medicines. It is a time-taking and resource-hungry task. It is the reason, only entrepreneurs with deep pockets can only think about it.

Healthcare companies with a superb track record can only do it
When a company like Piramal that has performed well in the healthcare business invests in medical research, there are several business benefits. Products developed by thorough research will be greatly effective, and they will add good revenues. It will change the face of the company.

The situation in India is also changing rapidly as the new government focuses on indigenous Pharma Research India. As liberal policies will come into existence, pharmaceutical companies will not feel the need of investing in foreign companies. It will save money for drug companies.